Clinical Trials Directory

Trials / Conditions / Grade IV Astrocytoma

Grade IV Astrocytoma

8 registered clinical trials studyying Grade IV Astrocytoma — 1 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingNovel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
NCT07416188
National Institute of Neurological Disorders and Stroke (NINDS)Phase 1 / Phase 2
Active Not RecruitingPeds CHAMP1ON - Hematopoietic Stem Cell And Monoclonal Antibody PD-1 Blockade for RecurreNt Pediatric High-Gra
NCT07031765
University of FloridaPhase 1
CompletedTadalafil to Overcome Immunosuppression During Chemoradiotherapy for IDH-wildtype Grade III-IV Astrocytoma
NCT04757662
Washington University School of MedicinePhase 1
Active Not RecruitingSurgical Nivolumab And Ipilimumab For Recurrent GBM
NCT04606316
Patrick Wen, MDPhase 1
CompletedConvection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma
NCT02858895
Medicenna Therapeutics, Inc.Phase 2
TerminatedPhase-1 Study of Folinic Acid to Modulate MGMT Gene in Glioblastoma
NCT01700569
Institut Cancerologie de l'OuestPhase 1
CompletedStudy To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma
NCT01290692
TVAX BiomedicalPhase 2
UnknownStudy of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
NCT00045968
Northwest BiotherapeuticsPhase 3